{
    "clinical_study": {
        "@rank": "85577", 
        "arm_group": [
            {
                "arm_group_label": "Control Group", 
                "description": "No intervention to be performed."
            }, 
            {
                "arm_group_label": "Ultrasound Group", 
                "description": "All will receive nerve and muscle ultrasound."
            }
        ], 
        "brief_summary": {
            "textblock": "Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease\n      affecting motor neurons. Early diagnosis is essential for the success of clinical trials and\n      objective biomarkers are needed for monitoring disease progression.  Nerve and muscle\n      ultrasound may provide this information.\n\n      This study will collect pilot data to evaluate the value of muscle and nerve ultrasound to\n      identify and monitor disease progression in ALS."
        }, 
        "brief_title": "Neuromuscular Ultrasound in ALS", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "ALS", 
        "condition_browse": {
            "mesh_term": "Amyotrophic Lateral Sclerosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects referred to the electromyography laboratory for ALS.\n\n        Exclusion Criteria:\n\n          -  Patients with known comorbid myopathy or neuropathy will be excluded from the study.\n\n          -  Patients unable to provide their own consent will be excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients referred to the electromyography laboratory for ALS."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785550", 
            "org_study_id": "Pro00042025"
        }, 
        "intervention": {
            "arm_group_label": "Ultrasound Group", 
            "description": "Ultrasound of 6 muscles and 2 nerves will be performed.", 
            "intervention_name": "Ultrasound of nerve and muscle", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 3, 2014", 
        "location": {
            "contact": {
                "email": "lisa.hobsonwebb@duke.edu", 
                "last_name": "Lisa D Hobson-Webb, M.D.", 
                "phone": "919-668-2277"
            }, 
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University Medical Center"
            }, 
            "investigator": {
                "last_name": "Lisa D Hobson-Webb, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Ultrasonography in Amyotrophic Lateral Sclerosis as a Predictor of Disease Progression and Tool in Diagnosis: a Pilot Study", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Ultrasound measures will be compared to electromyography measures at the patient's initial assessment.  The number of abnormal muscles will be counted using each technique and analyzed to determine if one test is superior.", 
            "measure": "Abnormalities at onset: Ultrasound vs. Electromyography", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785550"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The initial ultrasound measures and patient outcomes, as measured by standard validated scales, will be assessed at periodic intervals for one year.  Analysis will be performed to determine if ultrasound measures can predict the clinical course.", 
            "measure": "Ultrasound Predicting Outcome at 1 year", 
            "safety_issue": "No", 
            "time_frame": "1.5 years"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}